Inventor
Naphtali REYNA
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07BGeneral methods of organic chemistry5%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
12,565,490Inhibitors of Receptor Interacting Protein Kinase I for the treatment of disease202612,286,406Inhibitors of receptor interacting protein kinase I for the treatment of disease202511,753,381Inhibitors of receptor interacting protein kinase I for the treatment of disease202311,718,612Inhibitors of receptor interacting protein kinase I for the treatment of disease202311,713,313GLS1 inhibitors for treating disease202311,690,850Inhibitors of receptor interacting protein kinase I for the treatment of disease202311,173,145Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to UNIV TEXAS (7)· patent assignee history
2021–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEXAS | 7 | 2021–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2026 |